Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 21, 2019CirculationOpen Access

Targeted Therapeutics for Transthyretin Cardiac Amyloidosis

View Full Paper
Ask AI
Bookmark
Share

Authors

Sanjiv J. Shah
Sanjiv J. ShahHeart Failure / Cardiomyopathy

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sanjiv J. Shah (2019) studied this question.

synapsesocial.com/papers/6aa8fbe07ea61a08df43ecc7https://doi.org/10.1161/circulationaha.118.037593
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis2018 · 1,454 citations
  2. 2Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis2018 · 3,051 citations
  3. 3Fully Automated Echocardiogram Interpretation in Clinical Practice2018 · 1,018 citations
  4. 4Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction2014 · 1,157 citations
  5. 5Individual response to treatment: is it a valid assumption?2004 · 178 citations